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Although propofol is commonly used for general anesthesia,  its direct eﬀects on left ventricular (LV) 
contractility and energetics remain unknown.  Accordingly,  we studied the eﬀects of intracoronary 
propofol on excised cross-circulated canine hearts using the framework of the Emax (a contractility 
index)-PVA (systolic pressure-volume area,  a measure of total mechanical energy)-Vo2 (myocardial 
oxygen consumption per beat) relationship.  We obtained 1) the Vo2-PVA relationship of isovolumic 
contractions with varied LV volumes at a constant Emax,  2) the Vo2-PVA relationship with varied LV 
volumes at a constant intracoronary concentration of propofol,  and 3) the Vo2-PVA relationship under 
increased intracoronary concentrations of either propofol or CaCl2 at a constant LV volume to assess 
the cardiac mechanoenergetic eﬀects of propofol.  We found that propofol decreased Emax dose-
dependently.  The slope of the linear Vo2-PVA relationship (oxygen cost of PVA) remained unchanged 
by propofol.  The PVA-independent Vo2-Emax relationship (oxygen cost of Emax) was the same for 
propofol and Ca2＋.  In conclusion,  propofol showed a direct negative inotropic eﬀect on LV.  At its 
clinical concentrations,  decreases in contractility by propofol were relatively small.  Propofol shows 
mechanoenergetic eﬀects on the LV that are similar to those of Ca2＋ blockers or ß-antagonists—i.e.,  it 
exerts negative inotropic eﬀects without changing the oxygen costs of Emax and PVA.
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ropofol has been reported to have multiple 
actions on the myocardium by inhibiting L-type 
Ca2＋ channels [1],  sarcoplasmic reticulum (SR) Ca2＋
handling [2],  and K＋ channels [3],  and increasing 
Ca2＋ sensitivity [4].  The combination of these nega-
tive and positive inotropic mechanisms of propofol has 
the potential to result in complex outcomes of cardiac 
contractility.  While earlier studies using open chest 
canine hearts tried to determine the direct eﬀect of 
propofol on the pump function of the left ventricle 
(LV),  it remains unclear whether propofol has a nega-
tive inotropic eﬀect on beating hearts because simul-
taneous hemodynamic changes or neural regulation can 
aﬀect cardiac contractility [5-7].  To resolve this 
issue,  a rigorous analysis of LV contractility without 
concomitant changes in preload,  afterload and barore-
ﬂex activity is needed to elucidate the inotropism of 
propofol.  Moreover,  although an eﬀect of propofol on 
myocardial oxygen consumption has been reported in 
several studies [6-8],  the energetic eﬀects of propo-
fol on a beating whole heart remain unknown.
　 The purpose of this study was to analyze the over-
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all eﬀects of propofol on cardiac mechanoenergetics in 
the excised (denervated) cross-circulated (blood-per-
fused) canine heart.  To evaluate the cardiac inotropic 
eﬀect of propofol,  we used the most reliable contrac-
tility index,  Emax,  which is practically independent 
of ventricular loading conditions [9,  10].  To assess 
the eﬀects of propofol on cardiac energetics,  we used 
the relationship between Vo2 (myocardial oxygen con-
sumption per beat) and PVA (systolic pressure-volume 
area: a measure of total mechanical energy) of the LV 
[9].
Materials and Methods
　 All procedures in this study were approved by the 
Okayama University Institutional Review Board.
　 Surgical preparation. We performed the 
experiments on the excised,  cross-circulated canine 
heart preparation (Fig.  1) [11,  12].  The left atrium 
of the excised heart was opened and a latex balloon 
mounted on a rigid connector was ﬁtted into the LV.  
LV pressure was measured with a pressure gauge 
(model P-7; Konigsberg Instruments,  Pasadena,  CA,  
USA) placed inside the apical end of the balloon.  The 
water-ﬁlled balloon was connected to a custom-made 
volume servopump (Air-Brown,  Tokyo,  Japan) that 
controlled the LV volume.
　 The heart was paced at 129±11 (beats/min),  
～20ｵ above the spontaneous heart rate at ～37.0℃.  
We adopted the isovolumic contraction mode because 
the Vo2-PVA relation is largely independent of the 
contraction mode [9].
　 Oxygen consumption. Total coronary blood 
ﬂow (CF) was measured with an electromagnetic 
ﬂowmeter (MFV-3200; Nihon Kohden,  Tokyo,  Japan).  
The coronary arteriovenous O2 content diﬀerence 
(AVO2D) was measured with an in-line oximeter 
(PWA-200S; Shoe Technica Inc.,  Chiba,  Japan).  The 
Vo2 was obtained as CF×AVO2D/heart rate [11,  
12].
　 Emax and PVA. LV contractility Emax was 
determined as the maximum ratio of P(t)/[V(t)-V0] 
[10],  where V0 was the volume at which peak isovolu-
mic pressure was zero.  PVA was calculated as the 
area in the P-V diagram as schematically shown in 
Fig.  2A.  Emax and PVA were normalized for 100 
gLV.
　 Experimental protocol. The experiments con-
sisted of 4 runs in each of 5 hearts:
　 1. Control volume run: We obtained the volume 
loaded Vo2-PVA relationship (Fig.  2B) of steady-state 
isovolumic contractions produced at 4-10 diﬀerent LV 
volumes (6-24ml).
　 2. Propofol volume run: Under coronary infusion 
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Fig. 1　 Schematic illustration of the canine cross-circulated heart preparation.  
LV,  left ventricle; LVP,  LV pressure; ECG,  electrocardiogram; AVO2D,  arterio-
venous O2 content diﬀerence; CF,  coronary ﬂow.
of propofol that decreased Emax to ～70ｵ of the 
control level,  we obtained another Vo2-PVA relation 
(Fig.  2C) by varying the LV volume.  The propofol 
concentration was measured by high-performance liq-
uid chromatography.
　 3. Propofol and calcium inotropism runs: We 
performed a propofol inotropism run to obtain a dif-
ferent type of Vo2-PVA relationships at a single,  ﬁxed 
LV volume.  Propofol was infused intracoronarily to 
vary Emax,  Vo2,  and PVA,  and then we obtained the 
Vo2-PVA relationship (Fig.  2C).  We depressed Emax 
to approximately half the control level by increasing 
the propofol concentration in steps to 60 µg/ml.
　 We next infused CaCl2 (1ｵ) in steps to increase 
Emax to approximately double the control value.  We 
used calcium rather than catecholamine because cal-
cium does not aﬀect the complex phosphorylation 
processes of contractile proteins [13].
　 Data analyses
　 1. Vo2-PVA relations: Vo2 and PVA data in vol-
ume runs were subjected to linear regression analysis 
(Fig.  2B): Vo2＝a･PVA＋b,  where a is the slope of 
the regression line and b is the Vo2 intercept.  a･PVA 
represents PVA-dependent Vo2 and b represents PVA-
independent Vo2.  The coeﬃcient a was the oxygen cost 
of PVA [10].
　 Vo2 and PVA data in each inotropism run were also 
subjected to linear regression analysis to obtain a 
composite Vo2-PVA relation (Fig.  2C).
　 2. PVA-independent Vo2: The PVA-independent 
Vo2 for each Emax level during either the propofol or 
calcium run was calculated as the Vo2 minus PVA-
dependent Vo2 for the respective PVA.  This PVA-
dependent Vo2 was calculated as the product of the 
same slope value a and the PVA of this contraction.  
The PVA-independent Vo2 at each Emax level was 
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Fig. 2　 Schematic illustration of the framework of the relation among left ventricular Emax (a contractility index),  PVA (systolic pres-
sure-volume area: a measure of total mechanical energy),  and Vo2 (myocardial O2 consumption per beat) used in the present study.  Emax,  
the slope of the end-systolic pressure-volume relation,  sensitively reﬂects ventricular contractility (Panel A).  PVA correlates linearly with 
Vo2 in a load-independent manner in a stable contractile state (Panel B).  The slope (a) of the Vo2-PVA relation at a constant Emax repre-
sents the O2 cost of PVA.  Vo2 can be divided at the Vo2 intercept (b) of the Vo2-PVA relation into the PVA-independent and the PVA-
dependent Vo2 components (Panel B).  The PVA-dependent Vo2 is related to cross-bridge cycling.  The PVA-independent Vo2 is related to 
the total Ca2＋ handling in the excitation-contraction coupling and basal metabolism.  Panel C indicates that the Vo2-PVA data point devi-
ates from a data point of the control Vo2-PVA relation with changes in Emax by an inotropic intervention at a constant LV volume.  This 
steeper relation (composite Vo2-PVA relation) traversed multiple volume-loaded Vo2-PVA relations for diﬀerent contractility (Emax) levels.  In 
this relation,  the PVA-independent Vo2 increases or decreases in proportion to an increase or a decrease in Emax,  respectively.  The slope 
(c) of the relation between the PVA-independent Vo2 and Emax represents the O2 cost of Emax,  and the y intercept (d) of this relation 
indicates the PVA-independent Vo2 at zero Emax,  which is nearly equal to the basal metabolism (Panel D).
calculated as LV Vo2 minus a･PVA.
　 3. Oxygen cost of Emax: The relation between 
PVA-independent Vo2 values and the corresponding 
Emax values in either the propofol or calcium inotro-
pism run was obtained by regression analysis in each 
heart (Fig.  2D).  The slope c of the regression line 
was identiﬁed as the oxygen cost of Emax [10].  We 
used calcium rather than a catecholamine as a positive 
inotropic agent because calcium administration increases 
cardiac contractility without primarily involving the 
phosphorylation processes of contractile proteins [14].
　 Preliminary experiment. To conﬁrm the eﬀect 
of propofol on the LV basal metabolism,  we per-
formed KCl-arrest runs in the control and under 
propofol infusion (n＝3,  60 µg/ml).  The heart was 
arrested at V0 by a continuous infusion of 0.3mol/l 
KCl solution at 1-2.5ml/min into the coronary artery.  
When CF and AVO2D reached a steady state during 
KCl arrest,  Vo2 was measured as basal metabolic Vo2.  
PVA-independent Vo2 consists of oxygen consumption 
for excitation-contraction (E-C) coupling and basal 
metabolism (Fig.  2B).  Propofol did not aﬀect basal 
metabolic Vo2 (0.92±0.63 in the control and 0.91±
0.71ml O2･min－1･100g－1 in propofol infusion).
　 Statistical analysis. The Vo2-PVA regression 
lines were compared between propofol and calcium 
inotropism runs and between control and propofol 
volume runs in each heart by the analysis of covari-
ance (ANCOVA).  The signiﬁcance of the diﬀerences 
in their slopes and elevations was tested by the F test.  
ANCOVA was also used to compare the regression 
lines of PVA-independent Vo2 on Emax between the 
propofol and calcium inotropism runs.  Comparison of 
paired mean values was performed by Studentʼs paired 
t-test.  A value of p＜0.05 was considered statistically 
signiﬁcant.  All data are expressed as the mean ± SD.
Results
　 Control and propofol volume runs. Fig.  3A 
shows the Vo2-PVA relations obtained in control and 
propofol volume runs in a heart.  There were no sig-
niﬁcant diﬀerences in the slopes between the two Vo2-
PVA relations in any of the 5 hearts: the values were 
(1.75±0.36)×10－5 in the control and (1.73±0.32)
×10－5ml O2･mmHg－1･ml－1 in the propofol volume 
run,  indicating that propofol did not aﬀect the oxygen 
cost of PVA.  Propofol signiﬁcantly decreased the Vo2 
intercept value (0.0202±0.0029 in the control to 
0.0152±0.0044ml O2･beat－1･100g－1 in the propofol 
volume run).
　 Composite Vo2-PVA relations of calcium and 
propofol inotropism runs. Fig.  3B shows the 
Vo2-PVA relationships in the control volume run and 
the calcium and propofol inotropism runs.  The Vo2-
PVA data points descended more sharply when Emax 
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Fig. 3　 (Panel A) Vo2-PVA relationships in the control volume run (open circles; Vo2＝1.76×10－5 PVA＋0.017,  r＝0.98) and the 
propofol volume run (closed circles; Vo2＝1.59×10－5 PVA＋0.01,  r＝0.964).  Propofol shifted the volume-loaded Vo2-PVA relation down-
ward in a parallel manner.  (Panel B) Vo2-PVA relationships in the control volume run (open circles; Vo2＝1.25×10－5 PVA＋0.022,  r＝
0.98),  the propofol inotropism run (closed triangles; Vo2＝4.43×10－5 PVA＋0.012,  r＝0.987) and the calcium inotropism run (open 
squares; Vo2＝4.89×10－5 PVA＋0.011,  r＝0.969).  The Vo2-PVA composite relations during the propofol inotropism run and calcium 
inotropism run (dashed and dotted lines) were steeper than the control volume loaded Vo2-PVA relationships (solid line).  The composite 
relations in the propofol and calcium inotropism runs are virtually superimposable (ANCOVA).
was decreased by propofol and ascended more steeply 
when Emax was increased by calcium than the volume 
loaded Vo2-PVA relationship.  The data points in the 
two inotropism runs moved in opposite directions,  but 
their linear relationships were superimposable.  The 
other four hearts also showed similar results.
　 Oxygen cost of Emax and dose-dependency of 
negative inotropism. Fig.  4A plots PVA-inde-
pendent Vo2 values against Emax values during the 
propofol and calcium inotropism runs in one heart.  
Here,  PVA-independent Vo2 decreased linearly when 
Emax was decreased by propofol and increased lin-
early when Emax was increased by calcium.  No sig-
niﬁcant diﬀerence was found in either the slope or 
elevation between these two PVA-independent Vo2-
Emax relationships.  The other four hearts showed 
similar results,  i.e.,  the same oxygen cost of Emax 
between propofol and calcium.
　 The representative patterns of Emax versus the 
intracoronary propofol concentrations are plotted as a 
percent of the control (no propofol infusion) in Fig.  
4B.  The ﬁtting line was drawn by linear regression 
analysis.  This ﬁgure shows the dose dependency of the 
negative inotropic eﬀect of propofol.  The mean value 
of the slopes was －1.71±0.88 µg－1･ml.
　 Eﬀects of propofol on LV contractility and 
other parameters. Table 1 compares Emax,  PVA,  
Vo2,  and other cardio-hemodynamic parameters obtained 
at an identical intermediate LV volume between the 
control and propofol volume runs in 5 hearts.  Propofol 
signiﬁcantly decreased LVP,  Emax,  PVA,  Vo2,  and 
AVO2D but did not signiﬁcantly aﬀect CF at a con-
stant LV volume.
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Fig. 4　 PVA-independent Vo2-Emax relationships in the propofol inotropism run (closed triangles; PVA-independent Vo2＝2.0×10－3 
Emax＋0.008,  r＝0.964) and the calcium inotropism run (open squares; PVA-independent Vo2＝2.0×10－3 Emax＋0.007,  r＝0.916) 
(Panel A).  Linear regression lines for the propofol inotropism run and calcium inotropism run are virtually superimposable (ANCOVA).  The 
slope of the lines indicates the oxygen cost of Emax.  The representative patterns of Emax versus blood propofol concentration in the 
propofol inotropism run are also shown (Panel B).  The regression line indicates the direct negative inotropism of propofol.
Table 1　 Eﬀect of propofol on left ventricular mechanoenergetics and coronary circulation in propofol volume run
LVP Emax PVA Vo2 CF AVO2D
Control 91.6±21.6　 8.4±2.8　 645±111　 0.042±0.013　 53±14 6.2±1.3　
Propofol 64.8±15.7＊ 5.9±2.0＊ 451±78＊ 0.029±0.010＊ 48±13 5.0±1.2＊
Each value (mean ± SD,  n＝5) was compared between control volume run and the propofol volume run at intracoronary blood propofol 
concentration (14.2±5.6 µg･ml－1) at a constant left ventricular (LV) volume (18.8±3.1 ml･100g－1) by Studentʼs paired t test.  ＊statistically 
signiﬁcant at p＜0.05.  LVP,  LV pressure (mmHg); Emax,  a contractility index (mmHg･ml－1･100g－1); PVA,  systolic pressure-volume area,  
a measure of total mechanical energy (mmHg･ml･beat－1･100g－1); Vo2,  oxygen consumption per beat (ml O2･beat－1･100g－1); CF,  coro-
nary ﬂow (ml･min－1･100g－1); AVO2D,  coronary arteriovenous oxygen content diﬀerence (vol%).
Discussion
　 We investigated the direct eﬀect of intracoronary 
propofol on the LV mechanoenergetics using the 
framework of the Emax-PVA-Vo2 relationship.  The 
results indicated that propofol exerted a dose-depen-
dent negative inotropic eﬀect without aﬀecting the 
oxygen cost of contractility.  Although the intact in situ 
whole heart preparation [7,  8] is meaningful to assess 
the clinical relevance,  many complicating factors,  e.g.,  
the changes in various ventricular loading conditions 
and neural reﬂexes,  would inevitably aﬀect the experi-
mental results.  Therefore,  the results obtained by 
experiments using blood-perfused,  normothermic,  and 
denervated whole canine hearts are essential to evalu-
ate the direct eﬀects of propofol on the LV contractil-
ity and mechanoenergetics.
　 Eﬀect of propofol on LV contractility. The 
present results showed that propofol decreased Emax 
in a dose-dependent manner.  Emax is virtually inde-
pendent of ventricular loading conditions,  unlike all 
other conventional myocardial contractility indices,  
including dP/dt max or Vmax [9].
　 In clinical use,  the required blood propofol concen-
trations for major and non-major surgery have been 
reported to be 4.05±1.01 µg/ml and 2.97±1.07 µg/
ml,  respectively [15].  When these average values are 
substituted into the regression line in Fig.  4B,  it can 
be seen that Emax decreases by only by 6.1ｵ for 
major surgery and 4.5ｵ for non-major surgery.  
Therefore,  the negative inotropism of propofol is 
relatively small within clinical concentrations.
　 Oxygen cost of PVA. Propofol did not aﬀect 
the oxygen cost of PVA and showed almost the same 
energetic eﬀects on the oxygen cost of Emax as cal-
cium,  though in an opposite direction.  Previous stud-
ies have reported that the oxygen cost of PVA 
remained unchanged even during negative and positive 
inotropic interventions with propranorol [16],  cal-
cium [17],  catecholamines [17],  fentanyl [11],  and 
isoﬂurane [12],  in normal canine hearts.  In contrast,  
diseased heart models such as the hyperthyroid rabbit 
heart [18] and postischemic stunned canine heart 
[19] have shown increased oxygen costs of Emax due 
to the reduced Ca2＋ sensitivity and the induced futile 
Ca2＋ cycling via the SR.  Propofol did not show oxy-
gen-consuming eﬀects like those seen in diseased 
hearts.  Therefore,  propofol preserved the overall 
myocardial eﬃciency of energy use from oxygen to 
total mechanical energy via ATP.
　 Oxygen cost of Emax. Propofol did not aﬀect 
the basal metabolism in the KCl-arrest run.  Therefore,  
the decreased PVA-independent Vo2 by propofol would 
be mainly due to a decrease in the required energy for 
the E-C coupling.
　 This E-C coupling energy is critically aﬀected by 
the fraction of Ca2＋ handled (i.e.,  released and removed) 
via the SR— i.e.,  the intracellular Ca2＋ recirculation 
fraction (RF)—because the internal (via the SR) Ca2＋ 
handling has a 2Ca2＋: ATP stoichiometry twice more 
eﬃcient than the Ca2＋: ATP stoichiometry of exter-
nal (transsarcolemmal) Ca2＋ handling [20].  The frac-
tion of calcium handled via the sarcoplasmic reticulum 
is controlled by the regulation of membrane proteins 
that induce inﬂux and eﬄux of calcium— i.e.,  the 
L-type calcium channel and sodium-calcium exchanger 
(NCX),  which cause cardiac contraction and relax-
ation.  It has been reported that propofol showed 
positive inotropism via the reverse mode of the NCX 
during diastole at a lower rate (＜0.5Hz),  and nega-
tive inotropism via the inhibition of the L-type calcium 
channel at a higher rate (＞0.5Hz) in rat hearts [21].  
Therefore,  the negative inotropism of propofol observed 
in this study could be partially due to the inhibition of 
the L-type calcium channel.
　 Considering the preserved PVA-independent Vo2-
Emax relationship in the propofol inotropism run in 
the present study and the enhanced myoﬁlament Ca2＋ 
sensitivity reported in the earlier study [4],  we can 
conjecture that propofol has at least 2 eﬀects on 
myocardial Ca2＋ handling—namely,  a decrease in Emax 
and an associated decrease in RF.  Another possible 
mechanism preserving the oxygen cost of contractility 
could be the anti-apoptotic eﬀects of propofol on car-
diomyocytes [22] and the resulting protective eﬀect of 
propofol on endothelial dysfunction,  which would 
improve coronary micro-circulation [23].  Although 
the present study did not elucidate further details of 
the individual mechanoenergetic factors,  it did help to 
clarify the overall eﬀects of propofol on the canine 
heart,  which is better than the rodent heart for mim-
icking human cardiac mechanoenergetics.
　 Clinical implications. Our present results 
indicate that propofol has a negative inotropic eﬀect 
over a wide concentration range,  and a non-signiﬁcant 
need of any decrement of propofol concentration in the 
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clinical situation.  The present results also suggest 
that the decrease in blood pressure during anesthetic 
induction with propofol mainly depends on factors 
other than cardiac contractility per se.
　 Propofol was found to maintain both the O2 cost of 
PVA and the O2 cost of Emax.  These results suggest 
that the actions of propofol on the heart are quantita-
tively similar to those of Ca2＋ blockers or ß-antago-
nists from the viewpoint of mechanoenergetics [9].
　 We focused on the eﬀects of propofol on the non-
ischemic heart preparation in this study and observed 
that intracoronary propofol did not signiﬁcantly change 
coronary ﬂow at a constant LV volume,  even at a 
higher dosage than is used clinically (Table 1).  As for 
the eﬀect of propofol on coronary circulation,  it has 
been reported that propofol confers protection against 
ischemic reperfusion injury [24].  On the other hand,  
propofol has been shown to diminish the protective 
eﬀects of sevoﬂurane against ischemic reperfusion 
injury by activating calcium/calmodulin-dependent 
protein kinase type II and by hyperphosphorylation of 
the ryanodine receptor-2,  causing a postischemic cal-
cium leakage from the SR [25].  Because coronary 
ﬂow is determined by multiple factors,  such as cardiac 
contractility (Gregg phenomenon) and production of 
NO or EDHF,  it will be important to further investi-
gate the eﬀects and action mechanisms of propofol 
under several ischemic conditions to obtain better 
clinical outcomes.
　 In conclusion,  we assessed the eﬀ ect of intracoro-
nary propofol on LV mechanoenergetics in excised 
cross-circulated canine hearts by using the Emax-
PVA-Vo2 relationship.  The present results indicated 
that intracoronary propofol had a negative inotropic 
eﬀect on the left ventricle without changing the O2 cost 
of Emax.
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